Dégi László Csaba, the President of the European Cancer Organisation and a member of the Board of Directors for the Organisation of European Cancer Institutes (OECI), shared on LinkedIn:
“Proud to join the Editorial Board of the Journal of Breakthroughs in Medicine and Science | JBMS | and celebrate the launch of its flagship specialty journal, the Journal of Breakthroughs in Immuno-Oncology.
The journal’s six Co-Editors-in-Chief bring together outstanding leadership across oncology, immunotherapy, and clinical research:
- Patrick Soon-Shiong – Billionaire physician, surgeon, scientist, inventor, and entrepreneur, internationally recognized for his work in cancer immunotherapy; affiliated with UCLA and Imperial College London.
- James L. Gulley – National Cancer Institute.
- Jeffrey Schlom – National Cancer Institute.
- Manuel (Manny) Hidalgo – Weill Cornell Medicine.
- David J. Kerr – University of Oxford / Weill Cornell Medicine.
- Alex A. Adjei – Cleveland Clinic Cancer Center.
Bringing together my work at Babeș-Bolyai University, the European Cancer Community Foundation, and the APSCO® research project, I look forward to contributing a perspective that connects scientific breakthroughs with psychosocial oncology, bioethics, comprehensive cancer care, and evidence-informed cancer policy.
Because progress in medicine is not measured by discovery alone, but by its impact on human lives! Thank you so much Yeva Margaryan, Managing Editor JBMS.”
You can also read:
KEYNOTE-975 Phase 3 Trial Tests Immunotherapy With Definitive Chemoradiotherapy
